FiltersReset Filters

With box warnings

Without box warnings

Branded

Generic

15 results

alhemo
(concizumab)
Novo Nordisk
Usage: Alhemo is indicated for routine prophylaxis to prevent or reduce bleeding episodes in adults and pediatric patients aged 12 and older with hemophilia A (factor VIII deficiency with inhibitors) and hemophilia B (factor IX deficiency with inhibitors).
desmopressin acetate
(Desmopressin Acetate)
Gland Pharma Limited
Usage: Desmopressin acetate injection is indicated for managing central diabetes insipidus, temporary polyuria and polydipsia after head trauma, and for hemophilia A and mild to moderate von Willebrand’s disease Type I to maintain hemostasis and reduce bleeding during surgeries and injuries.
feiba
(anti-inhibitor coagulant complex)
Takeda Pharmaceuticals America, Inc.
Usage: FEIBA is indicated for hemophilia A and B patients with inhibitors for controlling and preventing bleeding episodes, perioperative management, and routine prophylaxis to reduce bleeding frequency. It is not for treating bleeding due to coagulation factor deficiencies without such inhibitors.
hympavzi
(marstacimab-hncq)
Pfizer Laboratories Div Pfizer Inc
Usage: HYMPAVZI is indicated for routine prophylaxis to prevent or reduce bleeding episodes in patients aged 12 and older with hemophilia A (factor VIII deficiency) or hemophilia B (factor IX deficiency), both without inhibitors.
roctavian
(valoctocogene roxaparvovec-rvox)
BioMarin Pharmaceutical Inc.
Usage: ROCTAVIAN is indicated for the treatment of adults with severe hemophilia A (congenital factor VIII deficiency with factor VIII activity < 1 IU/dL) who do not have antibodies to adeno-associated virus serotype 5, as verified by an FDA-approved test.
tranexamic acid
(Tranexamic Acid)
Micro Labs Limited
Usage: Tranexamic acid injection is indicated for short-term use in patients with hemophilia to reduce or prevent hemorrhage and minimize the need for replacement therapy during and after tooth extraction.
tranexamic acid
(Tranexamic Acid)
Amneal Pharmaceuticals LLC
Usage: Tranexamic acid injection is indicated for short-term use (2 to 8 days) in patients with hemophilia to reduce or prevent hemorrhage and decrease the need for replacement therapy during and after tooth extraction.
tranexamic acid
(tranexamic acid)
Mylan Institutional LLC
Usage: Tranexamic acid injection is indicated for short-term use (2 to 8 days) in patients with hemophilia to reduce or prevent hemorrhage and decrease the need for replacement therapy during and after tooth extraction.
tranexamic acid
(Tranexamic Acid)
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
Usage: Tranexamic Acid Injection is indicated for short-term use in patients with hemophilia to reduce or prevent hemorrhage and decrease the need for replacement therapy during and after tooth extraction, typically for a duration of 2 to 8 days.
tranexamic acid
(Tranexamic acid)
NorthStar RxLLC
Usage: Tranexamic acid injection is indicated for short-term use in patients with hemophilia to reduce or prevent hemorrhage and decrease the need for replacement therapy during and after tooth extraction, typically lasting 2 to 8 days.

Medications for Hemophilia A

alhemo

desmopressin acetate

feiba

hympavzi

roctavian

tranexamic acid

tranexamic acid

tranexamic acid

tranexamic acid

tranexamic acid